NASDAQ:MRNS Stock Quote
0.5500
+0.00 (0.00%)
Marinus Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for patients with rare neurological disorders
The company's lead product candidate aims to provide effective treatment options for conditions such as epilepsy. By leveraging their expertise in pharmacology and extensive research, Marinus Pharmaceuticals is dedicated to advancing therapeutic solutions that improve the quality of life for patients suffering from debilitating neurological conditions. Their commitment to innovation and patient care drives their research and development efforts in the field of neurology.